NAD+ · Peptides · Research
Looking into anti-aging, NAD+ or peptides? Explore what is known, what is uncertain and what needs a clinician’s review. No promise to reverse aging.
Enrollment opens later. Consultation required.
Explore your options Know your options
Compare options to discuss with a clinician.
Longevity benefits in humans are not established. Off-label aging use carries risks.
Wanting to stay active and independent with age is a meaningful goal. Rapamycin is being studied in aging research, but benefits for human longevity or body composition are not established. It has FDA-approved medical uses; healthy-aging use is off-label and carries risks requiring careful clinical review.
Treatment benefits for energy or slowing aging are not established.
When low energy gets in the way of everyday life, understanding the cause comes first. NAD+ has a role in cellular energy processes, but that does not establish that NAD+ treatment improves energy or slows aging. This planned option is not currently available through Mednaro; formulation, route and safety require review.
Healthy-aging benefits are not established. Separate clinical and regulatory review is required.
Changes in strength or recovery can raise questions about hormones, but they do not diagnose a deficiency. Sermorelin stimulates growth-hormone release; meaningful benefits for healthy aging are not established. This planned option requires separate clinical, regulatory, formulation and monitoring review. No healthy-aging outcome is promised.
Treatment benefits for energy, detoxification or healthy aging are not established.
Feeling run down deserves a clear explanation and an appropriate care plan. Glutathione is an antioxidant made by the body, but that does not establish benefits from glutathione treatment for energy, detoxification or healthy aging. This planned option requires review of formulation, route and safety; those benefits are not promised.
Packaging is illustrative and does not confirm product, formulation or pharmacy availability. A consultation does not guarantee a prescription. Read important safety information
At a glance
| Option | What to discuss | Before choosing |
|---|---|---|
| Rapamycin (sirolimus) | Longevity benefits in humans are not established. Off-label aging use carries risks. | Individual evaluation; risks, formulation and availability reviewed before treatment. |
| NAD+ | Treatment benefits for energy or slowing aging are not established. | Individual evaluation; risks, formulation and availability reviewed before treatment. |
| Sermorelin | Healthy-aging benefits are not established. Separate clinical and regulatory review is required. | Individual evaluation; risks, formulation and availability reviewed before treatment. |
| Glutathione | Treatment benefits for energy, detoxification or healthy aging are not established. | Individual evaluation; risks, formulation and availability reviewed before treatment. |
Before you decide
Understand eligibility, limits and safety before considering treatment.
The planned focus is practical health and function: body composition, muscle health, metabolic health, nutrition and strength. It is not a promise of age reversal or a way to infer a hormone deficiency from how you look or feel.
An evaluation can consider your health history, goals, medicines and relevant findings. Testing may be considered when clinically appropriate. A laboratory number does not automatically justify treatment, and Mednaro has not confirmed a standard biomarker package or monitoring schedule.
Nutrition, medical weight management and maintenance may be relevant to body-composition goals. These are related areas to discuss, not an automatic bundle of prescriptions. Optional dietitian and meal services remain subject to availability and separate pricing confirmation.
Advanced options are secondary to evaluation and everyday health priorities. Planned options include rapamycin (sirolimus), NAD+, sermorelin and glutathione. These treatments are not currently available through Mednaro. Clinical suitability, exact products, prescribing arrangements and state availability must be confirmed before enrollment opens.
No. Rapamycin is FDA-approved for certain medical uses; use for healthy aging is off-label. Its benefits for longevity or body composition are not established. The approval status of rapamycin does not apply to NAD+, sermorelin or glutathione.
Rapamycin, also called sirolimus, is available in FDA-approved prescription products for conditions including kidney-transplant rejection prevention and lymphangioleiomyomatosis. It is an immunosuppressant with significant risks, including serious infections. Individual evaluation, interaction review and appropriate monitoring are required. Compounded sirolimus is not an FDA-approved finished product.
No guesswork
Pricing is being finalized. No payment is taken in this planner.
More ways to plan for care
Explore planned HSA/FSA payments and buy now, pay later options.
These payment options are not active yet. Acceptance, eligible expenses, financing approval, fees and repayment terms will be confirmed before enrollment. HSA/FSA eligibility depends on your plan and the expense; financing is subject to provider eligibility and terms.
Pricing & availability
Review included services and separate charges before payment.
No. Clinical enrollment is not yet open. You can explore this information and contact general support with administrative questions. Do not send medical history, medications or sensitive personal details by ordinary email.
Pricing will be shown before enrollment opens. What is included, any separate costs, insurance acceptance and cancellation terms will be explained before you choose care.
Services and treatment availability vary by state and clinical eligibility. Availability will be confirmed before enrollment opens.
Mednaro provides the technology experience and nonclinical support. Medical decisions are made by appropriately licensed clinicians through independent clinical groups. When prescribed, medication is dispensed by licensed third-party pharmacies. Fulfillment and follow-up arrangements will be confirmed before enrollment opens.
A consultation does not guarantee a prescription. A clinician may recommend further evaluation or another next step. Any payment and refund terms will be explained before a paid evaluation becomes available.
Keep exploring
